SCHEMBL6189495

SCHEMBL6189495

COc1cccc(OC)c1C(=O)c1c(C)[nH]c2ccc(NC(=O)C3CCC(=O)C3)cc12

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 1/20 0.45
PARP15 Q460N3 1/20 0.45
PARP10 Q53GL7 1/20 0.45
ULK1 O75385 1/20 0.41
HTR1A P08908 1/20 0.40
HTR1D P28221 1/20 0.40
HTR1B P28222 1/20 0.40
HTR2C P28335 1/20 0.40
POLB P06746 4/20 0.39
ALDH1A1 P00352 2/20 0.38
TP53 P04637 1/20 0.38
MTNR1A P48039 2/20 0.38
MTNR1B P49286 2/20 0.38
HPGD P15428 1/20 0.38
MALT1 Q9UDY8 1/20 0.38
MAPT P10636 1/20 0.37
LMNA P02545 1/20 0.37
MAOA P21397 1/20 0.37
MAOB P27338 1/20 0.37
MEN1 O00255 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6187035 0.89 PARP1 (0.48) PARP1PARP15PARP10ULK1ALDH1A1
SCHEMBL6190881 0.88 PARP1 (0.47) PARP1PARP15PARP10ULK1TP53
SCHEMBL6187015 0.88 ULK1 (0.49) ULK1HTR1AHTR1DHTR1BHTR2C
SCHEMBL6185392 0.88 MAOA (0.49) ULK1HTR1AHTR1DHTR1BHTR2C
SCHEMBL6188508 0.87 MAOA (0.51) ULK1POLBALDH1A1MTNR1AMTNR1B
SCHEMBL6185141 0.84 PARP1 (0.44) PARP1PARP15PARP10POLBMALT1
SCHEMBL6187011 0.84 PARP1 (0.42) PARP1PARP15PARP10ULK1MALT1
SCHEMBL6188504 0.79 GRM4 (0.51) ULK1HTR1AHTR1DHTR1BHTR2C
SCHEMBL6188460 0.77 MAOA (0.46) ULK1TP53HPGDMAPTLMNA
SCHEMBL6189327 0.76 HPGD (0.46) ULK1ALDH1A1TP53HPGDMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1554271-A1 SUBSTITUTED INDOLES AND THEIR USE AS HCV INHIBITORS Rigel Pharmaceuticals, Inc. (US) 2005-07-20 EP disclosed
WO-2004035571-A1 SUBSTITUTED INDOLES AND THEIR USE AS HCV INHIBITORS RIGEL PHARMACEUTICALS, INC. (US) 2004-04-29 WO disclosed